勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.
作者信息
Hu Xiaoyi, Bao Mingyang, Huang Jiacheng, Zhou Lin, Zheng Shusen
机构信息
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
出版信息
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
Abstract
[This corrects the article DOI: 10.3389/fonc.2020.541479.].
摘要
[本文更正了文章DOI：10.3389/fonc.2020.541479。]
相似文献
1
Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。
Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.
2
Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma.勘误：与原发性胆汁酸生物合成及肝细胞癌肿瘤微环境相关的线粒体相关预后生物标志物的鉴定。
Front Oncol. 2022 Jan 17;11:843623. doi: 10.3389/fonc.2021.843623. eCollection 2021.
3
Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.勘误：上调的LINC01667表达与肝细胞癌的不良预后相关。
Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.
4
Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis regulating the arachidonic acid metabolism.勘误：OIT3通过介导铁死亡调节花生四烯酸代谢，作为肝细胞癌的一种新型生物标志物。
Front Oncol. 2022 Oct 26;12:1038279. doi: 10.3389/fonc.2022.1038279. eCollection 2022.
5
Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.勘误：ASPM是一种预后生物标志物，与肾透明细胞癌和肝细胞癌中的免疫浸润相关。
Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.
6
Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.勘误：非编码RNA：肝细胞癌中索拉非尼耐药性的新兴调节因子
Front Oncol. 2020 Mar 3;10:277. doi: 10.3389/fonc.2020.00277. eCollection 2020.
7
Corrigendum: CDT1 is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.勘误：CDT1是一种用于肝细胞癌的新型预后和预测生物标志物。
Front Oncol. 2021 Nov 9;11:801970. doi: 10.3389/fonc.2021.801970. eCollection 2021.
8
Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients.勘误：GALAD模型的验证及中国患者肝癌检测新模型的建立。
Front Oncol. 2023 Apr 19;13:1170066. doi: 10.3389/fonc.2023.1170066. eCollection 2023.
9
Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma miR-145-SERPINE1 Axis.勘误：TARBP2缺失通过miR-145-SERPINE1轴驱动肝细胞癌进展。
Front Oncol. 2021 Sep 7;11:746958. doi: 10.3389/fonc.2021.746958. eCollection 2021.
10
Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.勘误：SPOCK1促进肝细胞癌的发展。
Front Oncol. 2023 Apr 19;13:1203745. doi: 10.3389/fonc.2023.1203745. eCollection 2023.
引用本文的文献
1
Identification of a seven-lncRNAs panel that serves as a prognosis predictor and contributes to the malignant progression of laryngeal squamous cell carcinoma.鉴定一个七lncRNA基因组合，其作为预后预测指标并促进喉鳞状细胞癌的恶性进展。
Front Oncol. 2023 May 2;13:1106249. doi: 10.3389/fonc.2023.1106249. eCollection 2023.
2
In Silico Analysis of MicroRNA Expression Data in Liver Cancer.肝癌中微小RNA表达数据的计算机分析
Cancer Inform. 2023 May 10;22:11769351231171743. doi: 10.1177/11769351231171743. eCollection 2023.
Zotero 插件